- What is BioLert's primary focus?
- BioLert is dedicated to the development and manufacture of medical devices for monitoring vital signs, with its initial product line targeting the epilepsy market.
- What is the status of BioLert?
- BioLert is currently inactive, having ceased operations in January 2021.
- When was BioLert founded?
- BioLert was founded in January 2010.
- What kind of device is BioLert developing?
- BioLert is developing an electro-medical device that combines smartwatch technology, a smartphone, and a patented algorithm to continuously monitor for and detect seizure events, supporting a remote monitoring solution for patients and caregivers.
- How much funding has BioLert raised in total?
- BioLert has raised a total of $130,000.
- When did BioLert receive its last funding round?
- BioLert received a Grant round in January 2012.
- Which investor participated in BioLert's Grant funding round?
- The American Epilepsy Research Foundation participated in BioLert's Grant funding round in January 2012.
- Does BioLert hold any patents?
- Yes, BioLert holds one patent.